Drawing for ORGANOSTART

USPTO serial 79392432

ORGANOSTART

Reviewed by CopyMark Law Group

Reg. 7726314Status 700Registered
Filing date
Status date
Registration date
Mar 18, 2025
Examiner
MARTYNOV,VIKTORIIA V
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ORGANOSTART?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roberto Ledesma

Roberto Ledesma Law Office of Roberto LedesmaP.O. Box 230692New York, NY 10023United States

Goods and services

ClassDescriptionStatusFirst use
041Teaching in the field of manufacturing, culturing and studying cells, tissues and organs in the medical, chemical, pharmaceutical and veterinary fields; providing training in the field of manufacturing, culturing and studying cells, tissues and organs in the medical, chemical, pharmaceutical and veterinary fields; organizing and conducting conferences, congresses, seminars, symposia, workshops, webinars and courses in the field of manufacturing, culturing and studying cells, tissues and organs in the medical, chemical, pharmaceutical and veterinary fields, in person and via the Internet; educational services, namely, conducting classes, seminars, workshops, in person or via the internet, and e-learning training programs in the field of manufacturing, culturing and studying cells, tissues and organs in the medical, chemical, pharmaceutical and veterinary fields; publication of newsletters in the field of manufacturing, culturing and studying cells, tissues and organs in the medical, chemical, pharmaceutical and veterinary fields; continuing education services, namely, providing continuing professional education in the form of classes, seminars, workshops, in person or via the internet, and e-learning training programs in the field of manufacturing, culturing and studying cells, tissues and organs in the medical, chemical, pharmaceutical and veterinary fields; non-downloadable electronic publications namely, newsletters, e-books, brochures, guidelines, blogs and manuals in the field of manufacturing, culturing and studying cells, tissues and organs in the medical, chemical, pharmaceutical and veterinary fields; publication of printed matter in the field of manufacturing, culturing and studying cells, tissues and organs in the medical, chemical, pharmaceutical and veterinary fields; publication of educational materials, namely, brochures, manuals, and handbooks in the field of manufacturing, culturing and studying cells, tissues and organs in the medical, chemical, pharmaceutical and veterinary fields; conducting distance learning instruction at the graduate and post-graduate levels via the Internet in the field of manufacturing, culturing and studying cells, tissues and organs in the medical, chemical, pharmaceutical and veterinary fields; educational services, namely, organizing and giving presentations in the field of manufacturing, culturing and studying cells, tissues and organs in the medical, chemical, pharmaceutical and veterinary fields; educational services, namely, conducting audio and visual presentations in the field of manufacturing, culturing and studying cells, tissues and organs in the medical, chemical, pharmaceutical and veterinary fields; education services, namely, providing tutorial sessions in the field of manufacturing, culturing and studying cells, tissues and organs in the medical, chemical, pharmaceutical and veterinary fieldsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 18, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 28, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 28, 2025FIMPFINAL DISPOSITION PROCESSED—
Sep 12, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 27, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 27, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 19, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 18, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 18, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 28, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 28, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 22, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 5, 2025RFNPREFUSAL PROCESSED BY IB—
Jan 2, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 19, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Dec 19, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 19, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 19, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 5, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 6, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 6, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 9, 2024RFNTREFUSAL PROCESSED BY IB—
Aug 22, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 22, 2024RFRRREFUSAL PROCESSED BY MPU—
Aug 17, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 16, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 12, 2024DOCKASSIGNED TO EXAMINER—
Apr 5, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 1, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 28, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance